Creative Planning’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$453K Buy
16,197
+2,778
+21% +$78.2K ﹤0.01% 3260
2026
Q1
$383K Buy
13,419
+873
+7% +$29.8K ﹤0.01% 3235
2025
Q4
$496K Sell
12,546
-309
-2% -$11.3K ﹤0.01% 2854
2025
Q3
$453K Buy
12,855
+809
+7% +$27.9K ﹤0.01% 2808
2025
Q2
$395K Sell
12,046
-1,235
-9% -$40.1K ﹤0.01% 2667
2025
Q1
$428K Buy
13,281
+1,558
+13% +$57.8K ﹤0.01% 2433
2024
Q4
$358K Buy
11,723
+280
+2% +$9.01K ﹤0.01% 2522
2024
Q3
$321K Buy
+11,443
New +$282K ﹤0.01% 2461
2023
Q4
Sell
-4,643
Closed -$203K 2771
2023
Q3
$203K Buy
+4,643
New +$227K ﹤0.01% 2230
2015
Q4
Sell
-50
Closed -$1K 4401
2015
Q3
$1K Buy
+50
New +$1.25K ﹤0.01% 4069

Other funds holding ATRC

Creative Planning's ATRC Position: Q2 2026 in Review

Creative Planning increased its AtriCure (ATRC) stake by 21% in Q2 2026, buying an estimated $78.2K and bringing the position to 16,197 shares worth $453K. The position accounts for ﹤0.01% of the portfolio, ranked #3260.

Creative Planning first reported a position in ATRC in Q3 2015 and has held it in 10 quarters since. The position peaked at $496K in Q4 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Creative Planning held 16,197 shares of AtriCure worth $453K as of Q2 2026.
  • Creative Planning bought 2,778 AtriCure shares in Q2 2026, an estimated $78.2K.
  • AtriCure made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3260 holding.
  • Creative Planning first reported a position in AtriCure in Q3 2015 and has held it in 10 quarters since.
  • Creative Planning's AtriCure position peaked at $496K in Q4 2025.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.